Scheduled for October 20, 2017 in Washington, DC, USA
Princeton, NJ—August 22, 2017—The International Society for Pharmacoeconomics and Outcomes Research (
ISPOR) and the International Society for Pharmacoepidemiology (
ISPE) announced their plans for a 1-day conference focused on real-world evidence. The “
ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making” is scheduled for October 20, 2017 in Washington, DC, USA.
As the use of real-world data to create evidence for health care decision making is rapidly expanding, the need for good practice guidance recommendations for real-world evidence has become increasingly important. To address this guidance gap, ISPOR and ISPE collaborated to create the “
Joint ISPOR/ISPE Special Task Force on Real-World Evidence in Health Care Decision Making.” The special task force has produced several companion papers that make specific recommendations for improving the transparency and reproducibility of real-world evidence for use in health care decision making, especially those decisions at the regulatory and payer levels.
The 1-day summit will provide a forum to review these special task force reports, consider the perspectives of key stakeholders, and discuss future steps that could help enable these recommendations.
Summit speakers include a number of global thought leaders on the issue, including
Marc Berger, MD, formerly with Pfizer;
Cathy Critchlow, PhD, Amgen;
Jacqueline Corrigan-Curay, MD, US Food and Drug Administration;
Tobias Gerhard, PhD, ISPE;
Wim Goettsch PhD, EuNetHTA JA3;
Laura Happe, PharmD, MPH, Humana;
Elizabeth Loder, MD, MPH, The BMJ;
C. Daniel Mullins, PhD, University of Maryland;
Eleanor Perfetto, PhD, MS, National Health Council;
Sebastian Schneeweiss, MD, ScD, Harvard Medical School;
Brian Strom, MD, MPH,
Pharmacoepidemiology and Drug Safety;
Harold Sox, MD, PCORI;
Shirley Wang, PhD, ScM, Harvard Medical School;
Richard Willke, PhD, ISPOR;
Deborah Zarin, MD, National Institutes of Health.
The papers from the special task force will be published in each Society’s respective journal, ISPOR’s
Value in Health and ISPE’s
Pharmacoepidemiology & Drug Safety.
Additional information on the summit can be found:
Summit Information |
Registration |
ISPOR Real-World Evidence Initiative |
Special Task Force |
Press
###
ABOUT ISPOR
The International Society for Pharmacoeconomics and Outcomes Research (
ISPOR) is a nonprofit, international, educational and scientific organization that promotes health economics and outcomes research excellence to improve decision making for health globally.
Web:
www.ispor.org | LinkedIn:
http://bit.ly/ISPOR-LIn | Twitter:
http://bit.ly/ISPOR-T (@ISPORorg) | YouTube:
http://bit.ly/ISPOR-YT | Facebook:
http://bit.ly/ISPOR-FB
ABOUT ISPE
The International Society for Pharmacoepidemiology (
ISPE) is a nonprofit international organization dedicated to advancing the health of the public by providing a global forum for the open exchange of scientific information and for the development of policy; education; and advocacy for the field of pharmacoepidemiology, including such areas as pharmacovigilance, drug utilization research, comparative effectiveness research, and therapeutic risk management.
Web:
www.pharmacoepi.org